Neuronal RNA Oxidation in Alzheimer's Disease and Down's Syndrome
- 1 November 1999
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 893 (1) , 362-364
- https://doi.org/10.1111/j.1749-6632.1999.tb07855.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s DiseaseJournal of Neuroscience, 1999
- Biomarkers of oxidative stress are significantly elevated in Down syndromeFree Radical Biology & Medicine, 1998
- Early Glycoxidation Damage in Brains from Down's SyndromeBiochemical and Biophysical Research Communications, 1998
- The Active Site of ICP47, a Herpes Simplex Virus–encoded Inhibitor of the Major Histocompatibility Complex (MHC)-encoded Peptide Transporter Associated with Antigen Processing (TAP), Maps to the NH2-terminal 35 ResiduesThe Journal of Experimental Medicine, 1997
- 4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's DiseaseJournal of Neurochemistry, 1997
- Oxidative damage in Alzheimer'sNature, 1996
- Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitroNature, 1995
- The Lack of Accumulation of Senile Plaques or Amyloid Burden in Alzheimerʼs Disease Suggests a Dynamic Balance Between Amyloid Deposition and ResolutionJournal of Neuropathology and Experimental Neurology, 1993